|A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy|
RJ Babaian, A Toi, K Kamoi, P Troncoso, J Sweet, R Evans, D Johnston, ...
The Journal of urology 163 (1), 152-157, 2000
|The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy|
RA Rendon, JR Kachura, JM Sweet, MR Gertner, MD Sherar, M Robinette, ...
The Journal of urology 167 (4), 1587-1592, 2002
|Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy|
MA Haider, P Chung, J Sweet, A Toi, K Jhaveri, C Ménard, P Warde, ...
International Journal of Radiation Oncology* Biology* Physics 70 (2), 425-430, 2008
|Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer|
C Parker, M Milosevic, A Toi, J Sweet, T Panzarella, R Bristow, C Catton, ...
International Journal of Radiation Oncology* Biology* Physics 58 (3), 750-757, 2004
|Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome|
JH Pinthus, M Witkos, NE Fleshner, J Sweet, A Evans, MA Jewett, ...
The Journal of urology 176 (3), 979-984, 2006
|Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens|
AJ Evans, PC Henry, TH Van der Kwast, DC Tkachuk, K Watson, ...
The American journal of surgical pathology 32 (10), 1503-1512, 2008
|V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression|
RK Nam, A Toi, D Vesprini, M Ho, W Chu, S Harvie, J Sweet, ...
Urology 57 (1), 199-204, 2001
|Transcriptional activity of androgen receptor is modulated by two RNA splicing factors, PSF and p54nrb|
X Dong, J Sweet, JRG Challis, T Brown, SJ Lye
Molecular and cellular biology 27 (13), 4863-4875, 2007
|Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma|
B Vukovic, PC Park, J Al-Maghrabi, B Beheshti, J Sweet, A Evans, ...
Oncogene 22 (13), 1978-1987, 2003
|Canadian consensus guidelines for the management of testicular germ cell cancer|
L Wood, C Kollmannsberger, M Jewett, P Chung, S Hotte, M O’Malley, ...
Canadian Urological Association Journal 4 (2), e19, 2010
|Development of a radiofrequency based thermal therapy technique in an in vivo porcine model for the treatment of small renal masses|
RA RENDON, MR GERTNER, MD SHERAR, MR ASCH, JR KACHURA, ...
The Journal of urology 166 (1), 292-298, 2001
|Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer|
RK Nam, WW Zhang, J Trachtenberg, MAS Jewett, M Emami, D Vesprini, ...
Cancer Epidemiology and Prevention Biomarkers 12 (12), 1429-1437, 2003
|PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade|
M Yoshimoto, K Ding, JM Sweet, O Ludkovski, G Trottier, KS Song, ...
Modern Pathology 26 (3), 435-447, 2013
|The ultrastructural localization of von Willebrand factor in endothelial cells.|
MJ Warhol, JM Sweet
The American journal of pathology 117 (2), 310, 1984
|The continuing importance of transrectal ultrasound identification of prostatic lesions|
A Toi, MG Neill, GA Lockwood, JM Sweet, LA Tammsalu, NE Fleshner
The Journal of urology 177 (2), 516-520, 2007
|Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression|
RK NAM, Y ELHAJI, MD KRAHN, J HAKIMI, M HO, W CHU, J SWEET, ...
The Journal of urology 164 (2), 567-572, 2000
|Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis|
B Beheshti, PC Park, JM Sweet, J Trachtenberg, MAS Jewett, JA Squire
Neoplasia (New York, NY) 3 (1), 62, 2001
|Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome|
P Turker, PJ Bostrom, ML Wroclawski, B van Rhijn, H Kortekangas, C Kuk, ...
BJU international 110 (6), 804-811, 2012
|A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer|
S Trudel, J Trachtenberg, A Toi, J Sweet, ZH Li, M Jewett, J Tshilias, ...
Cancer gene therapy 10 (10), 755-763, 2003
|Spermatocytic seminoma: a review|
PWM Chung, AJS Bayley, J Sweet, MAS Jewett, B Tew-George, ...
European urology 45 (4), 495-498, 2004